Australian Society for Colposcopy and Cervical Pathology Update
Tuesday 21st March 2017
Over the last 12 months the role of new technologies as an adjunct to colposcopy is being discussed more and more at international congresses.
Colposcopy may not have changed much over the last 90 years, but there is a change in mindset about how technologies such as ZedScan can improve accuracy and better manage patient outcomes during routine examinations.
Speaking at the Australian Society for Colposcopy and Cervical Pathology in Sydney, Pierre Martin-Hirsh included mention of ZedScan in his presentation ‘adjuncts to colposcopy – do we need them?’
David Wrede, the secretary of the ASCCP, also included reference to ZedScan in his talk about the official guidelines for the management of colposcopy. Zilico’s cervical cancer diagnostic system ZedScan, is the only adjunctive technology with TGA approval.
For more information about Zilico, please contact:
Zilico Ltd, tel: +44 161 826 7840; email: firstname.lastname@example.org or visit www.zilico.co.uk
For press enquiries, please contact:
Julia Price, tel: +44 7737 864 878; e-mail: email@example.comNews